DE60021196D1 - Apoptose induzierende proteinesubstanz - Google Patents

Apoptose induzierende proteinesubstanz

Info

Publication number
DE60021196D1
DE60021196D1 DE60021196T DE60021196T DE60021196D1 DE 60021196 D1 DE60021196 D1 DE 60021196D1 DE 60021196 T DE60021196 T DE 60021196T DE 60021196 T DE60021196 T DE 60021196T DE 60021196 D1 DE60021196 D1 DE 60021196D1
Authority
DE
Germany
Prior art keywords
apoptosis inducing
inducing protein
protein substance
apoptosis
novel therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60021196T
Other languages
English (en)
Inventor
Hubertus Noteborn
Bertram Weiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leadd BV
Original Assignee
Leadd BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leadd BV filed Critical Leadd BV
Application granted granted Critical
Publication of DE60021196D1 publication Critical patent/DE60021196D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE60021196T 1999-10-21 2000-10-20 Apoptose induzierende proteinesubstanz Expired - Lifetime DE60021196D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203467A EP1094110A1 (de) 1999-10-21 1999-10-21 Proteinsubstanz das Apoptose induziert
PCT/NL2000/000767 WO2001029226A2 (en) 1999-10-21 2000-10-20 Apoptosis inducing proteinaceous substance

Publications (1)

Publication Number Publication Date
DE60021196D1 true DE60021196D1 (de) 2005-08-11

Family

ID=8240768

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60021196T Expired - Lifetime DE60021196D1 (de) 1999-10-21 2000-10-20 Apoptose induzierende proteinesubstanz

Country Status (6)

Country Link
US (1) US20030054994A1 (de)
EP (2) EP1094110A1 (de)
AT (1) ATE299183T1 (de)
AU (1) AU1559501A (de)
DE (1) DE60021196D1 (de)
WO (1) WO2001029226A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ579478A (en) 2007-03-08 2012-08-31 Kalobios Pharmaceuticals Inc Epha3 antibodies for the treatment of solid tumors
KR20110008086A (ko) 2008-04-11 2011-01-25 메리맥 파마슈티컬즈, 인크. 인간 혈청 알부민 링커 및 그 콘쥬게이트
ES2719496T3 (es) 2008-11-12 2019-07-10 Medimmune Llc Formulación de anticuerpo
BRPI0921586A2 (pt) * 2008-11-18 2019-09-24 Merrimack Pharmaceuticals Inc articuladores de albumina de soro humana e conjugados destes
EA201101241A1 (ru) 2009-03-06 2012-04-30 Калобайос Фармасьютиклз, Инк. Лечение лейкозов и хронических миелопролиферативных болезней антителами к ерна3
WO2011005481A1 (en) 2009-06-22 2011-01-13 Medimmune, Llc ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
WO2012031273A2 (en) 2010-09-03 2012-03-08 Stem Centrx, Inc. Novel modulators and methods of use
JP6167040B2 (ja) 2010-11-05 2017-07-19 ザイムワークス，インコーポレイテッド Ｆｃドメイン中に突然変異を有する、安定したヘテロ二量体抗体の設計
EP4063391A1 (de) 2012-07-25 2022-09-28 Celldex Therapeutics, Inc. Anti-kit-antikörper und verwendungen davon
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0924296A3 (de) * 1997-12-03 2001-08-01 Leadd B.V. Verfahren un Mittteln für die Induktion von Apoptosis durch Interferenz in RNS-Prozessierung
GB9930519D0 (en) * 1999-12-24 2000-02-16 Phogen Limited Uses of transport proteins

Also Published As

Publication number Publication date
AU1559501A (en) 2001-04-30
ATE299183T1 (de) 2005-07-15
EP1222280B1 (de) 2005-07-06
US20030054994A1 (en) 2003-03-20
WO2001029226A2 (en) 2001-04-26
WO2001029226A3 (en) 2002-02-07
EP1222280A2 (de) 2002-07-17
EP1094110A1 (de) 2001-04-25

Similar Documents

Publication Publication Date Title
NO20074774L (no) Blandinger omfattende DNA-odeleggende midler og P53
ATE318590T1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
BR0209254A (pt) anticorpos de bloqueio cripto e usos dos mesmos
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE69830087D1 (de) Gerät zur therapeutischen Kauterisation von vorbestimmten Volumen biologischen Gewebes
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
DE60043305D1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69807634T2 (de) Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
NO20055838L (no) Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav
DE60021196D1 (de) Apoptose induzierende proteinesubstanz
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
ATE247466T1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DK1083224T3 (da) Apoptin-associerende protein
WO2001072825A3 (en) Apoptin-associating protein
ATE506947T1 (de) Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen
WO2001042461A3 (en) Apoptin-associating protein
EP1111045A3 (de) Apoptin-bindendes Protein
WO2001053351A3 (en) Apoptin bindendes protein
EP1138768A3 (de) Apoptin-bindendes Protein AAP-5
EP1118662A3 (de) Apoptin bindendes Protein
ITTO930537A0 (it) Dispositivo programmabile di controllo di infusori portatili di farma-ci, particolarmente per terapie ferrochelanti e simili.
DE59813114D1 (de) BK-RiV-Präparate zur Behandlung von proliferativen Zellerkrangungen

Legal Events

Date Code Title Description
8332 No legal effect for de